COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

Risk-Based Triaged Mammograms Demonstrate Success During Periods of Reduced Capacity

April 28th 2021

Triaging individuals with the highest likelihood of cancer detection with their clinical indication and individual risk factors during periods of reduced capacity could be an efficient way of identifying the most cancers with the least examinations compared with a non–risk-based approach.

Dr. Raz on the Effects of COVID-19 on Lung Cancer Screening

April 26th 2021

Dan J. Raz, MAS, MD, discusses the effects of COVID-19 on lung cancer screening.

Dr. Gralow on Future Challenges in Cancer Care in the Post–COVID-19 Era

April 23rd 2021

Julie R. Gralow, MD, discusses future challenges in cancer care following the COVID-19 pandemic.

Dr. Lavery on Achieving Safe Care for Esophagogastric Cancer During COVID-19

April 22nd 2021

Anita Lavery, MD, MRCP, discusses achieving safe care for patients with esophagogastric cancer during the COVID-19 pandemic.

CCC19 Updates Uncover High All-Cause Mortality in Patients With COVID-19 and Cancer Receiving Select Chemotherapies

April 21st 2021

Patients with cancer who have contracted COVID-19 trend towards having high disease severity and mortality, especially among those with select demographic and clinical characteristics, with certain chemotherapy regimens contributing towards a high all-cause mortality.

Dr. Au on the Results of a Subgroup Analysis Evaluating Antibody Response to COVID-19 in Cancer

April 21st 2021

Lewis Au, MBBS, BMedSci, FRACP, discusses the results of a subgroup analysis evaluating antibody responses to COVID-19 in patients with cancer.

Pandemic Intensifies the Struggle With Burnout in Cancer Field

April 21st 2021

The COVID-19 pandemic has added another burden, with growing evidence of its negative effects on the well-being of many cancer care providers.

Tocilizumab May Have Activity Against COVID-19–Associated Cytokine Storm in Myeloma

April 20th 2021

Tocilizumab may represent a potential treatment option with double action against cytokine storm due to COVID-19 in a subset of patients with active multiple myeloma and severe infection with the virus.

Dr. Charlton on the Effects of the COVID-19 Pandemic on HCC

April 20th 2021

Michael R. Charlton, MD, MBBS, discusses the effects of the COVID-19 pandemic on hepatocellular carcinoma.

Clinical Progress Creates Need for Decision-Support Tools

April 20th 2021

The current endorsement of 3 COVID-19 vaccines in the United States, with several additional products pending FDA review, in less than 1 year from the identification of the structure of the COVID-19 virus is simply remarkable.

Dr. Au on Antibody Responses to COVID-19 Observed in Patients With Cancer

April 15th 2021

Lewis Au, MBBS, BMedSci, FRACP, discusses antibody responses to COVID-19 observed in patients with cancer.

Telehealth Is Poised for a Post–COVID-19 Future

April 14th 2021

During the COVD-19 pandemic, the expansion of covered services for telehealth by the Centers for Medicare & Medicaid Services and private insurers has provided a safer alternative for patients and physicians.

Dr. del Rio on Remaining Questions With the COVID-19 Vaccines

April 13th 2021

Carlos del Rio, MD, discusses remaining questions with the COVID-19 vaccines.

Research Efforts in HER2+ Breast Cancer Pick Up Speed Despite COVID-19

April 9th 2021

Jane L. Meisel, MD, discusses sequencing questions, tucatinib combinations under exploration, and emerging strategies for use in the treatment of patients with HER2-positive breast cancer.

COVID-19 Jumpstarts RNA Cancer Vaccine Field

April 8th 2021

The success of the COVID-19 vaccines based on messenger RNA has led to a surge of interest from investigators, pharmaceutical companies, and investors in similar technology for other diseases, including a number of oncology indications.

Matsen Spotlights Best Practices for Breast Cancer Surgery Amidst the COVID-19 Crisis

April 7th 2021

The coronavirus disease 2019 pandemic had a tremendous impact on the surgical care of patients with breast cancer; practice patterns needed to be rapidly adjusted to continue to safely provide care during a time when resources were very limited.

COVID-19 Has Lessons for Oncology Clinical Trials

April 5th 2021

The coronavirus disease 2019 pandemic required that investigators, sponsors, and regulators adapt clinical trials to prioritize the safety of patients. Now momentum is gathering to make permanent the flexibilities introduced in regulations and procedures to improve access to clinical trials for patients with cancer.

Dr. Ip on the Utility of Investigational Treatments for COVID-19 in Oncology

March 31st 2021

Andrew Ip, MD, MS, discusses the utility of investigational treatments for COVID-19 in patients with cancer.

COVID-19 and Cancer Care: Lessons Learned 1 Year Later

March 31st 2021

From delayed diagnoses, to the emergence of telemedicine, to managing the increased emotional burden experienced by patients and healthcare professionals alike, the community has been forced to approach cancer care in ways they never had before in light of the COVID-19 pandemic.

Dr. Au on the Impact of COVID-19 on Cancer Care

March 29th 2021

Lewis Au, MBBS, BMedSci, FRACP, discusses the impact that COVID-19 has had and will continue to have on cancer care.